SCHEMBL17777288

SCHEMBL17777288

CC(=O)NC1C(O)[C@@H](O)C(CO)O[C@@H]1OC1C(O)[C@H](O[C@@H]2C(CO)O[C@@H](O)C(NC(C)=O)C2O)OC(CO)[C@@H]1O

nearest known ligand 0.59

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ LGALS3 P17931 6/20 0.59
▸ LGALS8 O00214 1/20 0.59
▸ LGALS4 P56470 1/20 0.59
▸ CD69 Q07108 1/20 0.56
▸ MAPK1 P28482 2/20 0.55
▸ CHIA Q9BZP6 1/20 0.55
▸ ALDH1A1 P00352 2/20 0.53
▸ THRB P10828 1/20 0.53
▸ LGALS1 P09382 1/20 0.49
▸ LGALS7; LGALS7B P47929 1/20 0.49
▸ LGALS9 O00182 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ KDM4E B2RXH2 1/20 0.44
▸ LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30387199 1.00 LGALS3 (0.59) LGALS3LGALS8LGALS4CD69MAPK1
SCHEMBL30483911 1.00 LGALS3 (0.59) LGALS3LGALS8LGALS4CD69MAPK1
SCHEMBL29399259 0.97 LGALS3 (0.63) LGALS3LGALS8LGALS4CD69MAPK1
SCHEMBL30527817 0.95 LGALS3 (0.59) LGALS3LGALS8LGALS4CD69MAPK1
SCHEMBL30651312 0.95 LGALS3 (0.59) LGALS3LGALS8LGALS4CD69MAPK1
SCHEMBL30570486 0.95 LGALS3 (0.59) LGALS3LGALS8LGALS4CD69MAPK1
SCHEMBL30653448 0.95 LGALS3 (0.59) LGALS3LGALS8LGALS4CD69MAPK1
SCHEMBL31701529 0.95 LGALS3 (0.59) LGALS3LGALS8LGALS4CD69MAPK1
SCHEMBL31701532 0.95 LGALS3 (0.59) LGALS3LGALS8LGALS4CD69MAPK1
Triacetylchitotriose SCHEMBL974524 0.95 CD69 (0.60) LGALS3LGALS8LGALS4CD69MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017082753-A1 GLYCOLIPID COMPOUNDS AND THEIR USES IN THE TREATMENT OF TUMOURS AGALIMMUNE LIMITED (GB) 2017-05-18 — — WO disclosed
WO-2016080850-A1 MULTIVALENT LIGAND-LIPID CONSTRUCTS BOVIN NICOLAI VLADIMIROVICH (RU) 2016-05-26 — — WO disclosed
Send feedback